169 related articles for article (PubMed ID: 12498856)
1. Preventing intraocular pressure increase after phacoemulsification and the role of perioperative apraclonidine.
Kasetti SR; Desai SP; Sivakumar S; Sunderraj P
J Cataract Refract Surg; 2002 Dec; 28(12):2177-80. PubMed ID: 12498856
[TBL] [Abstract][Full Text] [Related]
2. The effect of 1% apraclonidine on intraocular pressure after cataract surgery.
Sterk CC; Renzenbrink-Bubberman AC; van Best JA
Ophthalmic Surg Lasers; 1998 Jun; 29(6):472-5. PubMed ID: 9640568
[TBL] [Abstract][Full Text] [Related]
3. Effect of apraclonidine versus dorzolamide on intraocular pressure after phacoemulsification.
Onal S; Gozum N; Gucukoglu A
Ophthalmic Surg Lasers Imaging; 2005; 36(6):457-62. PubMed ID: 16355950
[TBL] [Abstract][Full Text] [Related]
4. The effect of 0.25% apraclonidine in preventing intraocular pressure elevation after Nd:YAG laser posterior capsulotomy.
Simsek S; Ertürk H; Demirok A; Cinal A; Yasar T; Karadenizli C
Eur J Ophthalmol; 1998; 8(3):167-72. PubMed ID: 9793771
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of acetazolamide and apraclonidine in the control of intraocular pressure following phacoemulsification.
Scuderi G; Regine F; Perdicchi A; Mannino G; Recupero SM
Ophthalmologica; 2006; 220(6):356-60. PubMed ID: 17095879
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of apraclonidine and acetazolamide in preventing postoperative intraocular pressure spikes after extracapsular cataract extraction.
Feist RM; Palmer DJ; Fiscella R; Ernest JT; Tripathi R; Torczynski E; Farber M
J Cataract Refract Surg; 1995 Mar; 21(2):191-5. PubMed ID: 7791061
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of apraclonidine 1% in preventing intraocular pressure rise following macular hole surgery.
Sciscio A; Casswell AG
Br J Ophthalmol; 2001 Feb; 85(2):164-8. PubMed ID: 11159479
[TBL] [Abstract][Full Text] [Related]
8. Effects of 0.5% and 0.25% apraclonidine on postoperative intraocular hypertension after cataract extraction.
Simşek S; Demirok A; Yaşar T; Cinal A; Bayram A; Yilmaz OF
Eur J Ophthalmol; 1998; 8(2):67-70. PubMed ID: 9673473
[TBL] [Abstract][Full Text] [Related]
9. Apraclonidine and anterior segment laser surgery. Comparison of 0.5% versus 1.0% apraclonidine for prevention of postoperative intraocular pressure rise.
Rosenberg LF; Krupin T; Ruderman J; McDaniel DL; Siegfried C; Karalekas DP; Grewal RK; Gieser DK; Williams R
Ophthalmology; 1995 Sep; 102(9):1312-8. PubMed ID: 9097768
[TBL] [Abstract][Full Text] [Related]
10. Effect of topical apraclonidine on the frequency of intraocular pressure elevations after combined extracapsular cataract extraction and trabeculectomy.
Robin AL
Ophthalmology; 1993 May; 100(5):628-33. PubMed ID: 8098520
[TBL] [Abstract][Full Text] [Related]
11. Brinzolamide 1% versus apraclonidine 0.5% to prevent intraocular pressure elevation after neodymium:YAG laser posterior capsulotomy.
Unal M; Yücel I; Akar Y
J Cataract Refract Surg; 2006 Sep; 32(9):1499-502. PubMed ID: 16931262
[TBL] [Abstract][Full Text] [Related]
12. Apraclonidine 0.5% versus brimonidine 0.2% for the control of intraocular pressure elevation following anterior segment laser procedures.
Chevrier RL; Assalian A; Duperré J; Lesk MR
Ophthalmic Surg Lasers; 1999 Mar; 30(3):199-204. PubMed ID: 10100253
[TBL] [Abstract][Full Text] [Related]
13. Medical control of intraocular pressure after cataract surgery.
Byrd S; Singh K
J Cataract Refract Surg; 1998 Nov; 24(11):1493-7. PubMed ID: 9818340
[TBL] [Abstract][Full Text] [Related]
14. Brimonidine 0.2% versus apraclonidine 0.5% for prevention of intraocular pressure elevations after anterior segment laser surgery.
Chen TC; Ang RT; Grosskreutz CL; Pasquale LR; Fan JT
Ophthalmology; 2001 Jun; 108(6):1033-8. PubMed ID: 11382625
[TBL] [Abstract][Full Text] [Related]
15. Effect of topical brinzolamide 1% and brimonidine 0.2% on intraocular pressure after phacoemulsification.
Cetinkaya A; Akman A; Akova YA
J Cataract Refract Surg; 2004 Aug; 30(8):1736-41. PubMed ID: 15313300
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of brimonidine 0.2% in controlling acute postoperative intraocular pressure elevation after phacoemulsification.
Katsimpris JM; Siganos D; Konstas AG; Kozobolis V; Georgiadis N
J Cataract Refract Surg; 2003 Dec; 29(12):2288-94. PubMed ID: 14709288
[TBL] [Abstract][Full Text] [Related]
17. Apraclonidine 0.5% versus 1% for controlling intraocular pressure elevation after argon laser trabeculoplasty.
Threlkeld AB; Assalian AA; Allingham RR; Shields MB
Ophthalmic Surg Lasers; 1996 Aug; 27(8):657-60. PubMed ID: 8858630
[TBL] [Abstract][Full Text] [Related]
18. Effects of apraclonidine on intraocular pressure and blood-aqueous barrier permeability after phacoemulsification and intraocular lens implantation.
Araie M; Ishi K
Am J Ophthalmol; 1993 Jul; 116(1):67-71. PubMed ID: 8101046
[TBL] [Abstract][Full Text] [Related]
19. Brimonidine 0.15% versus apraclonidine 0.5% for prevention of intraocular pressure elevation after anterior segment laser surgery.
Chen TC
J Cataract Refract Surg; 2005 Sep; 31(9):1707-12. PubMed ID: 16246772
[TBL] [Abstract][Full Text] [Related]
20. Randomised fellow eye comparison of the effectiveness of dorzolamide and apraclonidine on intraocular pressure following phacoemulsification cataract surgery.
Rainer G; Menapace R; Findl O; Georgopoulos M; Kiss B; Heinze G
Eye (Lond); 2000 Oct; 14 Pt 5():757-60. PubMed ID: 11116699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
